Causes of Obesity
Causes of Obesity
In general mankind, since the improvement of cookery, eats twice as much as nature requires.
—Benjamin Franklin,
American scientist, publisher, and diplomat There is a simple equation that explains how a person’s body maintains its weight. To maintain a steady body weight, the amount of energy a person takes in (the number [...]
Diet Pills: The Future
Diet Pills: The Future’
The quest for the perfect weight loss drug continues as the prevalence of obesity in the United States and other industrialized
countries rises.Why has it been so difficult for drug manufacturers to develop the “perfect” diet pill? One reason is that the causes of obesity are not [...]
Sanofi Allowed to Inform Patients Taking Acomplia That It Aids Blood Sugar Control
The European Commission has decided to let Sanofi-Aventis inform patients taking diet drug Acomplia (rimonabant) that the pill may also help in diabetic blood sugar control, but that does not mean it is approved to be prescribed as a diabetes drug.
The announcement, which ratified an [...]
Diet drug r Acomplia (rimonabant) was approved for sale on April 3rd by Switzerland for treatment of obese or overweight patients with at least one type of associated cardiovascular risk.
The approval by Switzerland, which is not a member of the European Union, is similar to the EU [...]
Diet Drug Acomplia (Rimonabant) to Use Name Zimulti in U.S.
It’s now official. If diet drug Acomplia (rimonabant) is ultimately approved for sale in the United States, the prescription diet pill will go on the U.S. market not as Acomplia but as Zimulti.
Sanofi-Aventis, developer of rimonabant which is now sold in a number of [...]
First Human Trial of Vaccine to Suppress Appetite Underway in Switzerland
Cytos Biotechnology of Zurich is enrolling obese volunteers in the first human trial of a vaccine designed to trigger antibodies to ghrelin, a human peptide, or hormone, that stimulates the appetite.
In the combined phase I/II clinical trial of the vaccine CYT009-GhrQb, the volunteers Acomplia (rimonabant) , who must [...]
Diet Drug Rimonabant (Acomplia / Zimulti) Approved for Sale in Brazil
Diet drug Acomplia (rimonabant) has been approved by ANVISA, the Brazilian health authority, for sale in Latin America’s largest country, drug-maker Sanofi-Aventis announced on April 26th.
Acomplia was approved by Brazil for use “as an adjunct to diet and exercise for [...]
Diet Drug Rimonabant (Acomplia) Significant Improves Glucose Control of Diabetic Patients
Diet drug Acomplia (rimonabant) significantly improved the blood glucose control of type 2 diabetic patients in a major clinical trial called ARPEGGIO, researchers reported on June 10th at the 68th Scientific Sessions of the American Diabetes Association.
The researchers said that patients in the multicenter trial who [...]
